This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds that target neurological and psychiatric disorders. Its structure, featuring a biphenyl moiety and a fluorine substituent, makes it valuable for creating molecules with specific binding affinity to receptors in the central nervous system. Additionally, it is employed in the development of drugs for pain management and inflammation due to its potential interactions with biological pathways. Researchers also explore its use in designing novel therapeutic agents for conditions like depression, anxiety, and neurodegenerative diseases.